Harald Sourij graduated sub auspiciis presidentis rei publicae 2004 from the Medical University of Graz, Austria where he subsequently did his training in General Medicine and Endocrinology and Metabolism.
In 2010 he moved to Oxford, UK and joined the Diabetes Trials Unit to work with Professor Rury Holman on diabetes outcome trials and served as the Clinical Lead for the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) and for the Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS).
In 2013 he returned to an Associate Professor position at the Medical University of Graz, Austria, where he is currently Deputy Director of the Division of Endocrinology and Diabetology, Head of the Diabetes Outpatient Clinic and Head of the Cardiovascular Diabetology Research group, which is currently running several clinical trials, including multicenter trials in heart failure.
His research activities focus mainly on diabetes and its cardiovascular complications. He has published over 100 peer-reviewed manuscripts and book chapters in highly ranked journals including The Lancet, Cell Metabolism, European Heart Journal or Diabetes Care.
Harald Sourij is a member of the Diabetes & Cardiovascular Disease Study Group of the EASD and is currently Secretary of the Austrian Diabetes Association. He has been awarded the Langerhans Award of the Austrian Diabetes Association in 2013 and the Joseph Skoda Award of the Austrian Society for Internal Medicine in 2015.